Curated metabolic health research from PubMed and leading YouTube channels
Subscribe via RSSShowing 1-12 of 12 articles
ATX-304, a groundbreaking diabetes drug, shows promise in improving metabolic health by reducing blood sugar and fatty liver without relying on insulin.
RNA-based biomarkers are transforming diabetes diagnostics and treatment by revealing underlying mechanisms and individual risks, paving the way for precision medicine.
Recent research reveals how Tent5 poly(A) polymerases stabilize insulin mRNA, providing insights into insulin production regulation and implications for diabetes management.
This study reveals how an intermittent energy restriction diet can improve metabolic diseases like MASLD and T2DM by modulating the gut-liver axis.
A new method called M4 drug discovery enhances predictions for GLP-1 receptor agonists, improving diabetes treatment outcomes through integrated data analysis.
A recent study highlights the alarming rates of polypharmacy and potentially inappropriate prescribing among older adults in Ghana, emphasizing the need for better clinical practices.
The PROVEN-DIA trial aims to evaluate lifestyle interventions for preventing type 2 diabetes in Brazil, comparing telehealth and hybrid delivery methods. This study could significantly impact diabetes prevention strategies in middle-income settings.
Explore the emerging therapies targeting gut-pancreatic peptides that revolutionize treatment for type 2 diabetes, obesity, and liver disease.
The passing of South African actor Seputla Sebogodi highlights the serious complications of diabetes, a condition affecting millions. His legacy reminds us of the importance of metabolic health awareness.
Combining a low-carb diet with GLP-1 medications may enhance insulin sensitivity and metabolic health. This approach shows promise for those managing diabetes.
This study explores how proteomic analyses can identify potential drug targets for cardiovascular disease, linking proteins to metabolic health outcomes.
New research reveals how metabolic stress and aging reshape pancreatic inflammation, highlighting distinct immune responses that could inform diabetes treatments.